Growth Metrics

Incyte (INCY) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Incyte (INCY) over the last 15 years, with Sep 2025 value amounting to $2.11.

  • Incyte's EPS (Weighted Average and Diluted) rose 290.74% to $2.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.90, marking a year-over-year increase of 4114.29%. This contributed to the annual value of $0.15 for FY2024, which is 94.34% down from last year.
  • Per Incyte's latest filing, its EPS (Weighted Average and Diluted) stood at $2.11 for Q3 2025, which was up 3.43% from $2.04 recorded in Q2 2025.
  • In the past 5 years, Incyte's EPS (Weighted Average and Diluted) ranged from a high of $2.54 in Q4 2021 and a low of -$2.04 during Q2 2024.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $0.80 (2025), whereas its average is $0.71.
  • As far as peak fluctuations go, Incyte's EPS (Weighted Average and Diluted) surged by 1,271.43% in 2021, and later tumbled by 326.67% in 2024.
  • Quarterly analysis of 5 years shows Incyte's EPS (Weighted Average and Diluted) stood at $2.54 in 2021, then plummeted by 95.28% to $0.12 in 2022, then skyrocketed by 641.67% to $0.89 in 2023, then rose by 6.74% to $0.95 in 2024, then skyrocketed by 290.74% to $2.11 in 2025.
  • Its last three reported values are $2.11 in Q3 2025, $2.04 for Q2 2025, and $0.80 during Q1 2025.